Latest news with #FrontiersinNeuroscience
Epoch Times
3 days ago
- Health
- Epoch Times
Japanese Gardens Calm the Mind—Here's What Makes Them So Effective
The earliest major treatise on Japanese gardens dates back to the 11th century. Yet some of the ancient design principles—such as capturing the spirit of nature—are still in use today. Could there be something about this garden style that is especially good for fostering relaxation? Research shows that exposure to nature induces positive feelings, but not all green spaces are equally therapeutic, according to a Eye Movement and Lower Stress The study, published in Frontiers in Neuroscience, adds to our understanding of how garden viewing offers a prescription-free method of reducing physiological and psychological signs of stress.
Globe and Mail
01-04-2025
- Health
- Globe and Mail
Renowned Biomedical Scientist Franco Cavaleri Challenges Conventional Alzheimer's Theories in Groundbreaking Study
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Franco Cavaleri, Ph.D.c, a distinguished biomedical research scientist and CEO of Biologic Pharmamedical Research and Manufacturing, has published a pioneering study that reexamines the role of amyloid β-peptides (Aβ) in Alzheimer's disease (AD). This research, featured in Frontiers in Neuroscience, proposes a paradigm shift in understanding the function of Aβ, suggesting they may serve a protective role against metal toxicity in the brain rather than being primary culprits in AD progression. A Protective Perspective on Amyloid β-Peptides Alzheimer's disease has long been associated with the accumulation of amyloid plaques, leading to the prevailing belief that Aβ contributes directly to neurodegeneration. Cavaleri's study challenges this notion by presenting evidence that Aβ and the enzyme β-secretase (BACE1) are integral to a cellular defense mechanism aimed at sequestering harmful metal ions. This chelation process may prevent oxidative stress and neuronal damage by neutralizing metal-induced toxicity. It is only when this protective system becomes overwhelmed by excessive metal exposure that neurodegenerative symptoms emerge. Implications for Alzheimer's Research and Treatment This groundbreaking perspective opens new avenues for Alzheimer's research, emphasizing the need to explore environmental factors, such as metal exposure, in disease development. By shifting the focus from solely targeting Aβ for therapeutic intervention to understanding its protective functions, scientists can develop more effective strategies that address the root causes of neurodegeneration. Franco Cavaleri: A Leader in Biomedical Innovation Franco Cavaleri's extensive background in nutritional biochemistry and natural medicine pharmacology has positioned him at the forefront of biomedical research. As CEO and Research Director of Biologic Pharmamedical Research and Manufacturing, Cavaleri has dedicated his career to bridging the gap between natural health products and pharmaceutical science. His work has led to significant advancements in understanding inflammation, neurodegenerative diseases, and the pharmacology of natural compounds. Beyond his groundbreaking research, Franco Cavaleri is the best-selling author and host of the Potential Within podcast, and a former IFBB Mr. North America Bodybuilding Champion. His powerful personal story—overcoming severe ulcerative colitis without surgery through targeted natural medicine and science-backed supplementation—fuels his mission to transform modern health care. Through innovations like his patented Curcumin BioBDMC30™, Ashwith™ Ashwagandha, Keto BHB-BA™, and Glyvia™ sweetener (among over 15 other patents), Cavaleri is redefining what proactive health looks like. His integrative approach fuses rigorous biomedical science with holistic lifestyle and nutraceutical interventions, offering a sustainable solution to an overburdened healthcare system. By empowering individuals to take control of their health through nutrition, precision supplementation, and evidence-based self-care, Cavaleri's work aims not only to reduce dependency on conventional medicine—but to enable longer, healthier, and more vibrant lives. About Biologic Pharmamedical Research and Manufacturing Biologic Pharmamedical Research and Manufacturing, based in Vancouver, Canada with manufacturing facilities in both Canada and the USA, specializes in the research and development of evidence-based nutraceuticals and pharmaceuticals. Under Cavaleri's leadership, the company focuses on innovative solutions that merge natural medicine with modern pharmacological principles to address complex health challenges as well as prevention. BiologicPharmaMedical Access the Full Study For a comprehensive understanding of this transformative research, the full study is available at Frontiers in Neurology. Media Contact Christina Weizmann Communications Lead Phone: 604.684.9321 Email: christina.w@ Business Development Contact Mike Schmidt VP Business & Product Development Phone: 1.855.518.8858 Email:
Saba Yemen
19-02-2025
- Health
- Saba Yemen
Study: Phonophobia linked to genetic factors
Amsterdam - Saba: A recent study has shown that the hatred of sounds that some people suffer from is linked to genetic factors such as anxiety and depression, and that those with this condition were more likely to have genes linked to psychological disorders as well as tinnitus. The study, published in the journal "Neurology" Frontiers in Neuroscience, says that while most people can feel uncomfortable when someone scrapes their nails on a chalkboard, those who suffer from hatred of sounds can have an equally strong reaction to sounds such as sipping, snoring, breathing and chewing. The survey conducted in 2023 suggests that hatred of sounds is more widespread than previously thought, and research from Europe suggests that this condition shares genes with anxiety, depression and post-traumatic stress disorder. University of Amsterdam psychiatrist Dirk Smit and colleagues analyzed genetic data from the Psychiatric Genomics Consortium, the UK Biobank, and the 23andMe databases, and found that people who identified themselves as having phonophobia were more likely to have genes linked to psychiatric disorders as well as tinnitus. Patients with tinnitus — a persistent, intense ringing in the ears — were also more likely to have psychiatric symptoms such as depression and anxiety. "There was also overlap with PTSD genes," Smit told Eric W. Dolan at PsyPost. 'This means that genes that confer susceptibility to PTSD also increase the likelihood of developing phonophobia, and this may suggest a common neurobiological system that affects both. This may suggest that treatment techniques used for PTSD could also be used to treat phonophobia." This doesn't necessarily mean that phonophobia and other illnesses have common mechanisms, just that some of the genetic risk factors may be similar. Previous research has found that people with aversion to sound are more likely to internalize their distress. Research by Smith and his team, published in 2023, also backed this up, showing strong links with personality traits such as anxiety, guilt, loneliness, and neuroticism. 'Responses to a triggering sound can range from annoyance and anger to distress that interferes with daily life… It has been suggested that… voice hatred is based on feelings of guilt over the triggered annoyance and anger rather than on behavioral expressions of the anger itself that cause distress,' Smith and his team wrote. People with autism spectrum disorder (ASD) were less likely to develop voice hatred. This was unexpected because people with ASD have a lower tolerance for voices. The study results suggest that voice hatred and ASD are relatively independent disorders with respect to genetic variation,' the researchers wrote in their paper. "This raises the possibility that there are other forms of voice hatred, one that is often triggered by conditioning anger or other negative emotions to specific sounds that are modified by personality traits." Smit and his colleagues caution that their data were mostly European, so the same associations may not be seen in different populations. Furthermore, voice hatred was not diagnosed medically in the data samples they obtained, but was self-reported. Only self-reported, which could also distort the results. But their study also provides clues about where further research could focus to find the biological mechanism behind voice hatred. Whatsapp Telegram Email Print more of (Press)
